Search clinical trials for: WMSDsQ
Total 1 results
-
Istituto Ortopedico GaleazziUnknownMusculoskeletal Diseases | Work-Related Condition
Sponsors and Collaborators
- Rivierduinen, Centre for Personality disorders Jelgersma
- Eurotrials Brasil Consultores Cientificos Ltda
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Arsha Vidya Tirtha
- Korea Otsuka International Asia Arab
- Lilly PharmaceuticalCompany
- Gunkang Pharmaceuticals, Inc
- United States Department of Defense (DOD)
- Oblikue Consulting
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- University of Applied Sciences Jena
- Sudimplant SAS - Groupe TBR
- Foshan Sanshui District People's Hospital
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Iyad Naeem Muhammad, PhD
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Julian Taylor Green
- Plethora Solutions Ltd
- Paulo Sérgio Gomes Nogueira Borges
- S-Biotek Holding ApS
- View Full List
Medical Conditions
- Hypothermia Following Anesthesia, Sequela
- Brain Tumor, Primary
- Deformity Flexion
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Advance Directive Completion
- Puberty, Delayed
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Serum Albumin Low
- Gray Platelet Syndrome
- Visual Attention Span Deficit
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Anemia Acute
- Huntington Chorea
- Blepharospasm of Both Eyelids
- Malaria,Falciparum
- Thyroid and Parathyroid Surgery
- Testicular Teratoma
- Vibration; Exposure
- Chemotherapy-Induced Neutropenia
- Immunologically-induced Lung Disease
- View Full List
Drug Interventions
- S-Adenosyl-Methionine
- Cytisine
- Pemetrexed
- MMV390048 120mg
- ABY-035 i.v.
- F520
- Rovalpituzumab tesirine
- Furmonertinib 160 mg
- Ebselen
- Acalabrutinib in combination with VR
- Standard medical therapy
- Mineralocorticoid receptor antagonist
- Vosaroxin
- Bimatoprost 0.03% eye drops
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Sorafenib
- Cyanoacrylate
- Oxycodone
- Celecoxib
- Pegfilgrastim
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Austria
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Egypt
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Ireland
- Contract Research Organizations in Poland
- Contract Research Organizations in Romania
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Venezuela
- CRO list by country